Emmaus Life Sciences, Inc. Common Stock
EMMA
EMMA was delisted on the 10th of September, 2019.
9 hedge funds and large institutions have $47.1K invested in Emmaus Life Sciences, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
29% more funds holding
Funds holding: 7 → 9 (+2)
65% less capital invested
Capital invested by funds: $136K → $47.1K (-$88.9K)
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.56K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$923 |
| 3 |
Barclays
London,
United Kingdom
|
+$32 |
| 4 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$16 |
Top Sellers
| 1 |
HFM
Hartford Financial Management
Hartford,
Connecticut
|
-$4.05K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Cannell & Co
New York
| $24K | – | – | – |
|
|
FFA
2
First Foundation Advisors
Irvine,
California
| $19K | – | – | – |
|
|
HFM
3
Hartford Financial Management
Hartford,
Connecticut
| $3K | -$4.05K | -250 | -34% |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | +$2.56K | +158 | +5,267% |
|
|
FCB
5
First Command Bank
Fort Worth,
Texas
| $119 | – | – | – |
|
|
6
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$16 | +1 | New |
|
|
7
Barclays
London,
United Kingdom
| – | +$32 | +2 | New |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | +$923 | +57 | +2,850% |
|
EMMA Hedge Fund Activity: Q1 2018 in Review
9 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Emmaus Life Sciences, Inc. Common Stock (EMMA) for Q1 2018, worth a combined $47.1K — down 65% from $136K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new EMMA positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $2.56K. The largest seller was Hartford Financial Management, cutting an estimated $4.05K.
- 9 institutional investors held Emmaus Life Sciences, Inc. Common Stock (EMMA) as of Q1 2018, up from 7 in Q4 2017.
- Funds reported $47.1K of Emmaus Life Sciences, Inc. Common Stock stock for Q1 2018, down 65% quarter-over-quarter.
- 2 funds opened new Emmaus Life Sciences, Inc. Common Stock positions in Q1 2018 and 0 closed out, a net change of +2 holders.
- The largest Emmaus Life Sciences, Inc. Common Stock buyer in Q1 2018 was UBS Group, an estimated $2.56K added.
- The largest Emmaus Life Sciences, Inc. Common Stock seller in Q1 2018 was Hartford Financial Management, an estimated $4.05K sold.
Based on aggregated 13F filings for Q1 2018.